Polo‐like kinase 4 inhibitor CFI‐400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity : Hepatology

Secondary Logo

Journal Logo

Original Articles: Liver Cancer

Polo‐like kinase 4 inhibitor CFI‐400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity

Chan, Cerise Yuen‐Ki1,2; Yuen, Vincent Wai‐Hin1,2; Chiu, David Kung‐Chun1; Goh, Chi‐Ching1; Thu, Kelsie L.3; Cescon, David W.3; Soria‐Bretones, Isabel3; Law, Cheuk‐Ting1; Cheu, Jacinth Wing‐Sum1,2; Lee, Derek1,2; Tse, Aki Pui‐Wah1,2; Tan, Kel Vin4; Zhang, Misty Shuo1,2; Wong, Bowie Po‐Yee1; Wong, Chun‐Ming1,5; Khong, Pek‐Lan4; Ng, Irene Oi‐Lin1,5; Bray, Mark R.3; Mak, Tak Wah2,3; Yau, Thomas Chung‐Cheung5,6; Wong, Carmen Chak‐Lui1,2,5,7

Author Information
Hepatology 77(3):p 729-744, March 2023. | DOI: 10.1002/hep.32461
  • Buy
  • SDC
  • Infographic

Abstract

Copyright © 2023 American Association for the Study of Liver Diseases.

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid